# Trade Mark Journal No.2026/002 9 January 2026

## WO0000001878480 (5)

Office of origin: United States of America

Date of International Registration:3 September 2025
Date of designation in the UK: 3 September 2025

International priority date claimed: 27 May 2025 (United States of America) (99203964)

Class 5
  Pharmaceutical preparations for use in the area of mental health care and the treatment of central nervous system diseases and disorders.

VistaGen Therapeutics, Inc.

Representative: David Lipson RAPHAEL BELLUM PLLC, 3190 Fairview Park Drive, Suite 550, Falls Church VA 22042, UNITED STATES OF AMERICA